rane skeleton, partially similar to kamebacetal A (6). 12) The conjugated carbonyl group (C-15) of 6 was reduced to a secondary hydroxyl in 1, and this assumption was confirmed by the heteronuclear multiple bond coherence (HMBC) correlations from H-15 (d was replaced by an OAc group in 1. The relative configuration of 1 was revealed by analysis of the rotating frame Overhauser effect spectroscopy (ROESY), in which the correlations of H-1 with H-5b and H-9b; H-14 with H-11a, H-12a, and H-13a; and H-15 with H-6b, H-7b, and H-17 were clearly observed, suggesting that the substituents at C-1, C-14, and C-15 possess a-, b-, and b-orientations, respectively ( Fig. 1 ). Since compound 1 is an ent-kauranoid on biogenetic grounds, 6 ) the configuration at C-20 was assigned as S* from the ROESY correlations between H-20 and H-19, H-6a. 13) Consequently, compound 1 was determined to be (20S*)-14b -acetoxy-1a ,15b -dihydroxy-20-methoxy-7a ,20-epoxyent-kaur-16-ene.
Rubluanin B (2), a white amorphous powder, was shown to possess the molecular formula C 21 H 32 O 5 from the quasimolecular ion peak observed at m/z 387.2154, [MϩNa] ϩ (Calcd 387.2147) in its HR-ESI-MS. Analyses of the 1 H-, 13 C-, and DEPT-NMR spectra suggested that it was also a 7,20-epoxy-ent-kauranoid, bearing a structure similar to kamebacetal A (6). One secondary hydroxyl group was assigned to C-15 in 2 as the HMBC spectrum showed correlations arising from H 2 -17, H-14a, H-13a and H-9b to C-15. ROESY correlations between H-1 and H-5b, H-9b; H-14 and H-11a, H-13a; H-15 and H-6b, H-7b, H-17 revealed the relative configuration of the substituents at C-1, C-14, and C-15 possess a-, b-, and b-orientations, respectively. Compound 2 also displayed ROESY correlations from H-20 to H-19, H-6a, and correlations from H-14a to H-OMe (at C-20). These correlations reflected that the configuration at C-20 was S*. Therefore, rubluanin B was assigned to be (20S*)-1a, 14b, 15b-trihydroxy-20-methoxy-7a,20-epoxyent-kaur-16-ene.
Rubluanin C (3), an epimer to 2, exhibited a quasi-molecular ion peak at m/z 387.2141 [MϩNa] ϩ (Calcd 387.2147) in its HR-ESI-MS, in agreement with the molecular formula C 21 H 32 O 5 . The only difference between them was the configuration at C-20. The ROESY spectrum of 3 showed correlations from H-20 to H-11a, H-14a, and H 3 -OMe (at C-20). Therefore the configuration at C-20 of 3 was determined as R*. Thus, the structure of compound 3 was elucidated as (20R*)-1a, 14b, 15b-trihydroxy-20-methoxy-7a,20-epoxyent-kaur-16-ene.
Rubluanin D (4), isolated as an amorphous white powder, showed a quasi-molecular ion peak at m/z 419. 2055 13 C-, and DEPT-NMR data (Tables 1, 2) suggested that 4 also had a 7,20-epoxy-ent-kaurane skeleton, partially similar to oridonin (9). 14) Two structural fragments, a (C-1 to C-3), and b (C-9 to C-14), were deduced from the 1 H-1 H COSY spectra as shown in Fig. 2 . Comparison of its 13 C-NMR data with those of oridonin revealed that the exomethylene of oridonin disappeared in 4, and 4 had one more additional methoxyl group. The methoxyl group was assigned to C-17 (d C 68.9) by the HMBC correlations arising from H 2 -17 (d H 3.83, 3.77) to C-OMe (d C 58.7), C-13 (d C 37.9), C-15 (d C 222.5), and C-16 (d C 52.1) (Fig. 2) . ROESY correlations between H-17 and H-12b, H-13a; H-16a and H-12b, H-13a indicated the configuration at C-16 was S*. Thus compound 4 was ultimately determined to be (16S*)-1a,6b,7b,14b-tetrahydroxy17b-methoxy-7a,20-epoxy-ent-kaur-15-one.
Dayecrystal B (5) was obtained as an epimer to compound 4. The only difference between them was the configuration at C-16. It gave a quasi-molecular ion peak at m/z 419.2049 [MϩNa] ϩ (Calcd 419.2045) in its HR-ESI-MS, corresponding to the molecular formula C 21 Thus compound 5 was finally established to be (16R*)-1a ,6b ,7b ,14b -tetrahydroxy-17a -methoxy-7a ,20-epoxy-entkaur-15-one, and the correction of its data assignment is given in Tables 1 and 2. The structures of other known compounds (6-15) were identified to be kamebacetal A (6), 12) henryin (7), 12) kamebakaurin (8), 16) oridonin (9), 14) isodonoiol (10), 17) megathyrin A (11), 18) lasiodonin (12), 19) lasiokaurin (13), 19) epinodosin (14) , 20) and 7-isopropyl-podocarpinol (15), 21) by comparison of their spectroscopic data with those reported in the literature. The results were generally consistent with the constituents reported in the literature, in which fifteen 20-oxygenated ent-kauranoids had been isolated from Isodon rubescens var. lushanensis collected in Lushan Prefecture of Henan Province.
Since only a minute amount of compound 1 was obtained it could not be tested for cytotoxicity. Compounds 2-14 were tested for their inhibitory effects in the human tumor cell lines (U937, Jurkat, HL-60, K562, SGC790, and HepG2), with 10-hydroxy-camptothecine as the positive control. The results are presented in Table 3 . Compounds 2 and 3 did not show bioactivity while their analogue kamebacetal A exhibited significant inhibitory effects in all of the cell lines, and this result was achieved mainly because the carbonyl groups that conjugated with the exomethylene group in kamebacetal A were replaced by secondary hydroxyl groups in compounds 2 and 3. For compounds 4 and 5, in their structures, the cyclopentanone group still remained, but their exomethylene groups were substituted by methoxyls, and then compounds 4 and 5 just showed weak activity in U937, Jurkat, HL-60, and K562, and they were not cytotoxic in SGC790 and HepG2. The above results further suggest that the cyclopentanone conjugated with an exomethylene group is the active center in ent-kauranoids.
22)

Experimental
General Procedures Optical rotations were measured on a PerkinElmer Model 241 polarimeter. UV absorptions were obtained on a Shimadzu UV-2401 PC UV-VIS recording spectrophotometer. IR spectra were deter-mined on a Bio-Rad Fts-135 spectrophotometer with KBr pellets. MS were recorded on a VG Auto spec-3000 spectrometer or Finnigan MAT 90 instrument. One-dimension and 2D-NMR spectra were run on Bruker AV-400 and DRX-500 instruments with TMS as an internal standard. Extraction and Isolation The dried and powdered stems and leaves (4.0 kg) were extracted with 70% acetone and filtered. After filtration and evaporation of the solvent under vacuum, the residue was suspended in water and partitioned with EtOAc. The EtOAc extract (117 g) was applied to column chromatography over a silica gel (100-200 mesh, 800 g) column eluted with a system of CHCl 3 -acetone (10 : 0, 9 : 1, 8 : 2, 7 : 3, 2 : 1, 1 : 1) to afford fractions A-F. Fraction B (28 g) was further chromatographed over MCI gel CHP-20 P (90% MeOH-H 2 O, then 100% MeOH) to yield fraction B 1 -B 3 . Fraction B 1 was further subjected to silica gel eluted with petroleum ether-acetone (1 : 0→0 : 1) to afford a mixture of two diterpenoids, then semi-preparative RP18-HPLC (MeOH/H 2 O, 30 : 70, 3 ml/min, detector 238 nm) was applied to yield compounds 10 (4.1 mg) and 7 (11.3 mg). Fraction C (43 g) was further chromatographed on MCI gel CHP-20 P (90% MeOH-H 2 O, then 100% MeOH) to yield fraction C 1 -C 4 , and compound 6 (437 mg) was obtained by recrystallization in MeOH from the C 1 fraction. Fraction C 2 was further subjected to a silica gel eluted with petroleum ether-acetone (10 : 1→0 : 1) to afford a mixture of two diterpenoids, and then isolated by semi-preparative RP18-HPLC (ACN/H 2 O, 35 : 65, 3 ml/min, detector 210 nm) to yield compounds 1 (2.1 mg) and 6. Compounds 13 (7.0 mg) and 14 (4.8 mg) were obtained by recrystallization in MeOH from the C 3 fraction after repeated chromatography over silica gel and RP-18 column (30-100% MeOH). Compound 8 (5.8 mg) was obtained by semipreparative RP18-HPLC (ACN/H 2 O, 27 : 73, 3 ml/min, detector 238 nm) from the C 4 fraction after repeated chromatography. Compound 12 (3.6 mg) was also obtained by semi-preparative RP18-HPLC (MeOH/H Cell viability was assessed by conducting colorimetric measurements of the amount of insoluble formazan that formed in living cells based on the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma, U.S.A.). 23) Briefly, 100 ml of adherent cells were seeded into each well of 96-well cell culture plates and allowed to adhere for 12 h before drug addition, while suspended cells were seeded just before drug addition, both with an initial density of 1ϫ10 5 cells/ml in 100 ml of medium. Each tumor cell line was exposed to the tested compound at various concentrations in triplicate for 48 h, with 10-hydroxy-camptothecine (Sigma, U.S.A.) as positive control. After the incubation, MTT (100 mg) was added to each well, and the incubation continued for 4 h at 37°C. The cells were lysed with 100 ml of 20% SDS-50% DMF after removal of 100 ml of medium. The optical density of the lysate was measured at 595 nm in a 96-well microtiter plate reader (Bio-Rad 680, U.S.A.). The IC 50 value of each compound was calculated by the Reed and Muench method. Positive control: 10-hydroxy-camptothecine.
Plant Material Stems and leaves of
